ACOG
Alpha Cognition
--
--(--)
Market Open: --
--
--(--)
Post-Market: --
ACOG Profile
Alpha Cognition Inc.
A pre commercial biopharmaceutical company dedicated to developing treatment methods for patients with neurodegenerative diseases such as Alzheimer's disease
1452 Hughes Rd. Ste. 200 , Grapevine, Texas 76051
--
Alpha Cognition Inc., incorporated under the British Columbia Business Corporations Act (" BCBCA ") on November 15, 2017 as "Crystal Bridge Enterprises Inc.", is a Canadian capital associate. On March 18, 2021, they completed a qualifying transaction with Alpha Cognition Canada Inc., and changed its name to Alpha Cogning Co., Ltd. Alpha Cognition, Inc., is a pre-commercialization stage biopharmaceutical company developing treatments for patients with neurodegenerative diseases such as Alzheimer's disease.